← FDA Drug Approvals (Drugs@FDA)

ACTAHIST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CENCI · Approved 1984-02-09

Drug application

FDA Application #

ANDA088344

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACTAHIST

Generic name

Pseudoephedrine Hydrochloride

Active ingredients

PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE

Dosage form

SYRUP

Route

ORAL

Marketing status

Discontinued

Sponsor

CENCI

First approval

1984-02-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown